Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on: March 30,2024

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on:March 30,2024

Sugar modifications the key to unlocking ovarian cancer secrets

byGriffith UniversityOvarian cancer research. Credit: Griffith UniversityThe ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and impr

Updated on: January 07,2024

Sugar modifications the key to unlocking ovarian cancer secrets

byGriffith UniversityOvarian cancer research. Credit: Griffith UniversityThe ability to identify unique sugars that decorate ovarian cancer cells could help prevent the spread of cancer and impr

Updated on:January 07,2024

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus

Updated on: January 23,2024

Conspiracy believers more likely to endorse mythical causes of cancer, finds study

byBritish Medical JournalCredit: Pixabay/CC0 Public DomainPeople who believe in conspiracies, reject the COVID-19 vaccine, or prefer alternative medicine are more likely to endorse mythical caus

Updated on:January 23,2024

Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on: January 13,2024

Newfound cancer cell biology suggests which patients will respond to immunotherapy

byNYU Langone HealthCredit: Pixabay/CC0 Public DomainPatients with head and neck cancer who have more genetic material on chromosome 9 in their cancer cells survive three times longer after rece

Updated on:January 13,2024

'Bad fat' suppresses killer T cells from attacking cancer

by Salk InstituteCredit: CC0 Public DomainIn order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized "killer" T cells. Salk research

Updated on: March 13,2024

'Bad fat' suppresses killer T cells from attacking cancer

by Salk InstituteCredit: CC0 Public DomainIn order for cancer to grow and spread, it has to evade detection by our immune cells, particularly specialized "killer" T cells. Salk research

Updated on:March 13,2024

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainResearchers at Baylor College of Medicine have discovered a crucial regulator of the anti-cancer immune response that could change t

Updated on: January 10,2024

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainResearchers at Baylor College of Medicine have discovered a crucial regulator of the anti-cancer immune response that could change t

Updated on:January 10,2024

Mainstreaming genetic counselling for ovarian cancer could support screening, in Malaysia and beyond

by European Society for Medical OncologyCredit: European Society for Medical OncologyA study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in

Updated on: April 23,2024

Mainstreaming genetic counselling for ovarian cancer could support screening, in Malaysia and beyond

by European Society for Medical OncologyCredit: European Society for Medical OncologyA study that looked at mainstreaming genetic counselling for ovarian cancer to support screening programmes in

Updated on:April 23,2024

Researchers characterize lung inflammation associated with some cancer immnunotherapy

by Johns Hopkins UniversityCredit: CC0 Public DomainImmune checkpoint inhibitors are a type of therapy that uses the immune system to fight cancer. They have been hailed as game changing, garneri

Updated on: June 08,2024

Researchers characterize lung inflammation associated with some cancer immnunotherapy

by Johns Hopkins UniversityCredit: CC0 Public DomainImmune checkpoint inhibitors are a type of therapy that uses the immune system to fight cancer. They have been hailed as game changing, garneri

Updated on:June 08,2024

Just bad luck? Australian cancer patients nominate 'fate' as third most likely cause

by University of South AustraliaCredit: CC0 Public DomainWhat role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia?Smoking, sun exposure,poor

Updated on: April 10,2024

Just bad luck? Australian cancer patients nominate 'fate' as third most likely cause

by University of South AustraliaCredit: CC0 Public DomainWhat role does fate play when it comes to the 145,000 people diagnosed with cancer each year in Australia?Smoking, sun exposure,poor

Updated on:April 10,2024

Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on: March 01,2024

Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on:March 01,2024

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on: April 14,2024

Cancer drug that targets two immune-evading tumor tactics performs well in early clinical trial

by University of PittsburghCredit: CC0 Public DomainA "two-for-one" cancer immunotherapy is potentially more effective and at least as safe as standard immunotherapies, physician-scient

Updated on:April 14,2024

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on: January 02,2024

Null result in nicotinamide (vitamin B3) skin cancer trial of organ-transplant recipients

by Justin Jackson , Medical XpressMicrograph of malignant melanoma. Cytology specimen. Field stain. Credit: Nephron/WikipediaA one-year, placebo-controlled trial of oral nicotinamide (vitamin B3) ther

Updated on:January 02,2024